AUS
NZ
UK
CA
USA
IND
On July 15, 2026, CACI International Inc. director Charles L. Szews disclosed a beneficial ownership change following the vesting of 85 restricted stock units (RSUs) on July 13, 2026. This vesting represents the third installment of four quarterly payments from an RSU grant awarded on October 16, 2025. After this transaction, Szews directly owns 584 shares of CACI common stock. This update offers insight into the director compensation structure at the Reston, Virginia-based government technology and services company.
Key Points
- NASDAQ ticker: CACI
- Director Charles L. Szews received 85 shares via RSU vesting on July 13, 2026, from the October 16, 2025 grant.
- Szews now holds 584 shares directly, with one final RSU vesting installment of 85 shares scheduled for October 11, 2026.
- Investors should monitor the upcoming fourth vesting installment under the same RSU award.
Charles Szews’ Role on CACI International’s Board
Charles L. Szews serves as a director of CACI International Inc. /DE/, a NASDAQ-listed government services and technology firm headquartered at 12021 Sunset Hills Road, Reston, Virginia 20190. He is not reported as a 10% owner or executive officer, holding his position solely as a board member. His registered address matches the company’s Reston corporate location.
As a non-employee director, Szews participates in equity-based compensation programs, including RSUs, designed to align directors’ interests with long-term shareholders. The filing does not indicate any additional equity holdings or derivative instruments beyond the disclosed RSU grant and resulting stock ownership.
Details of the July 13, 2026 RSU Vesting
On July 13, 2026, 85 RSUs converted into 85 shares of CACI common stock, recorded under transaction code "M" indicating exercise or conversion of derivative securities per Section 16 reporting standards. Szews acquired the shares directly without any concurrent sale or disposition. The disclosure notes no exercise price, consistent with typical RSU vesting where shares are delivered without cash payment. Post-transaction, Szews holds 584 shares of common stock directly.
Background on the October 2025 RSU Grant
The July 2026 vesting stems from an RSU award granted to Szews on October 16, 2025, totaling 338 units. This grant was structured to vest in four quarterly installments over roughly one year, linking equity compensation to ongoing board service.
The vesting schedule includes: 84 shares vested on January 14, 2026; 84 shares on April 14, 2026; 85 shares on July 13, 2026; and a final 85 shares scheduled for October 11, 2026. The minor difference in share counts between installments reflects rounding of the total 338 RSUs across four periods.
Previous Vesting Installments from the Same Grant
The July 2026 vesting is the third installment from the October 2025 RSU award. The first two installments of 84 shares each vested in January and April 2026, respectively, and were reported in earlier filings. To date, Szews has received 253 of the 338 RSUs granted, with the remaining 85 shares expected to vest in October 2026, completing the award contingent on continued board service.
Szews’ Ownership Position After the July Transaction
Following the July 13, 2026 vesting, Szews directly owns 584 shares of CACI common stock. The filing confirms no indirect holdings via trusts or related entities. This straightforward ownership reflects typical non-employee director equity compensation rather than larger holdings seen with executives or institutional investors. No open-market transactions or other dispositions related to these shares were reported.
Use of RSUs in CACI’s Director Compensation
RSUs are a common form of equity compensation for non-employee directors in U.S. public companies, vesting in alignment with continued board service. Szews’ October 2025 grant, vesting quarterly over approximately 12 months, exemplifies a structure designed to maintain alignment between director incentives and shareholder interests throughout the board term.
The quarterly vesting approach delivers equity incrementally rather than via a single lump sum, supporting ongoing engagement. The filing does not elaborate on CACI’s overall director compensation philosophy or any policy changes.
Remaining Derivative Securities Under the Grant
As of the July 13, 2026 transaction, 85 RSUs were converted into shares, with 85 RSUs remaining outstanding. These remaining units correspond to the fourth and final installment scheduled for October 11, 2026. Upon that vesting, the October 2025 RSU grant will be fully settled with no outstanding derivative securities. The filing does not disclose any other RSU grants, stock options, warrants, or convertible instruments held by Szews beyond this residual RSU balance.
Filing Date and Compliance Details
The disclosure was signed by Charles L. Szews on July 15, 2026, two business days after the July 13 transaction, complying with Section 16(a) reporting requirements that mandate insider reporting within two business days. The filing was submitted individually by Szews and is not an amendment to any prior report.
CACI International Inc. /DE/ is incorporated in Delaware and trades on NASDAQ under the symbol CACI. No immediate share price impact was evident from publicly available information.
Insights on Director Equity Ownership Trends at CACI
While routine, this RSU vesting event provides transparency into CACI’s board-level equity compensation practices. The quarterly vesting schedule indicates a deliberate strategy to link compensation with ongoing service rather than upfront or delayed equity delivery, a governance approach generally viewed positively.
The filing does not reveal new grants or changes to director compensation programs, nor does it include management commentary, earnings guidance, or strategic updates. Investors seeking broader insights into CACI’s financial performance and insider ownership should consult the company’s annual and quarterly reports, proxy statements, and other regulatory filings.
